US Broker Ratings

Pharvaris N.V. (PHVS) Stock Analysis: A Biotech with 41.23% Potential Upside

Pharvaris N.V. (PHVS) stands as a promising player in the biotechnology sector, focusing on therapies for rare diseases with unmet medical needs. Headquartered in Zug, Switzerland, Pharvaris has carved a..

Arbutus Biopharma Corporation (ABUS)

⚠️ No article content returned.

..

Cullinan Therapeutics, Inc. (CGEM) Stock Analysis: Biotech Innovator with 80% Upside Potential

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a clinical-stage biopharmaceutical company, stands out in the biotechnology sector with a promising pipeline targeting autoimmune diseases and cancer. With a market capitalization of $1.08..

Valneva SE (VALN) Stock Analysis: Assessing a Potential 139.86% Upside in Biotechnology

Valneva SE (NASDAQ: VALN), a French biotechnology company specializing in the development and commercialization of prophylactic vaccines, stands out in the healthcare sector with a compelling growth narrative. Despite recent..

Claritev Corporation (CTEV) Stock Analysis: Unveiling a 59.74% Potential Upside in Healthcare Analytics

Claritev Corporation (NASDAQ: CTEV), a pivotal player in the Healthcare Information Services industry, is making waves with its innovative solutions in data analytics and cost management. Headquartered in McLean, Virginia,..

Rocket Pharmaceuticals (RCKT) Stock Analysis: Exploring a 192% Potential Upside in Genetic Therapy Innovations

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is garnering attention in the biotechnology sector with its promising ventures in genetic therapies for rare and devastating diseases. Based in Cranbury, New Jersey, this..

Inventiva S.A. (IVA) Stock Analysis: Exploring a 227% Potential Upside in the Biotech Sector

Inventiva S.A. – American Depositary Shares (IVA) is making waves in the biotechnology sector with an impressive 227.15% potential upside, as indicated by the average target price of $15.11. This..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with 8.80% Revenue Growth in Focus

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector specializing in medical devices, showcases a blend of promising growth and underlying challenges. With a market capitalization of..

Tyra Biosciences, Inc. (TYRA) Stock Analysis: Unpacking the 57% Upside Potential and Analyst Consensus

Tyra Biosciences, Inc. (NASDAQ: TYRA) is currently capturing the attention of investors with its innovative approach in the biotechnology sector, focusing on precision medicines targeting fibroblast growth factor receptor (FGFR)..

Xencor, Inc. (XNCR) Investor Outlook: 31.84% Potential Upside in Biotech Innovation

Xencor, Inc. (NASDAQ: XNCR) stands as a compelling player in the biotechnology sector, with a focus on pioneering antibody therapies to combat cancer and autoimmune diseases. As a clinical-stage biopharmaceutical..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Unpacking a 59.68% Potential Upside in the Healthcare Sector

Castle Biosciences, Inc. (NASDAQ: CSTL), a promising player in the healthcare sector, is making waves with its focus on molecular diagnostics for dermatologic cancers and other serious conditions. With a..

Orthofix Medical Inc. (OFIX) Stock Analysis: A Promising 31.47% Upside in the Healthcare Sector

Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the medical devices industry, presents an intriguing investment opportunity for those interested in the healthcare sector. With a market capitalization of..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Exploring a Potential 455% Upside in the Biotech Sector

LENZ Therapeutics, Inc. (NASDAQ: LENZ), a burgeoning player in the biotechnology sector, is capturing attention with its intriguing focus on vision improvement therapies. For investors looking at the healthcare landscape,..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Why Investors Eye a 48.97% Upside Potential

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector, specializes in the development and commercialization of innovative pain management solutions. With a market cap of $1.17 billion,..

Simulations Plus, Inc. (SLP) Stock Analysis: Navigating the Healthcare Tech Landscape with a Modest Growth Potential

For investors keen on the intersection of healthcare and technology, Simulations Plus, Inc. (NASDAQ: SLP) presents a unique proposition. Operating within the healthcare sector, specifically the health information services industry,..

Butterfly Network, Inc. (BFLY) Stock Analysis: Navigating a 25% Revenue Growth in the Healthcare Sector

Butterfly Network, Inc. (BFLY), a trailblazer in the healthcare sector, has been making waves with its innovative handheld ultrasound imaging solutions. As a player in the competitive medical devices industry,..

Arvinas, Inc. (ARVN) Stock Analysis: A Potential 78% Upside for Biotechnology Enthusiasts

Arvinas, Inc. (ARVN), a clinical-stage biotechnology innovator based in New Haven, Connecticut, is capturing the attention of investors with its pioneering approach to tackling disease-causing proteins through targeted protein degraders...

Definitive Healthcare Corp. (DH) Stock Analysis: A 206.79% Potential Upside Beckons Investors

Definitive Healthcare Corp. (NASDAQ: DH) stands at a compelling juncture for investors seeking to explore opportunities in the healthcare information services sector. With a current market cap of $75.67 million,..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A Biotech Powerhouse with Nearly 100% Upside Potential

Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company based in Boston, Massachusetts, is at the forefront of developing innovative therapies for central nervous system (CNS) disorders. With a..

ArriVent BioPharma, Inc. (AVBP): Analyst Ratings Suggest 45% Upside Potential for This Biotech Contender

ArriVent BioPharma, Inc. (AVBP), a clinical-stage biopharmaceutical company, is capturing investor attention with its potential for significant upside. With a robust focus on addressing unmet medical needs in cancer treatment,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds